Christie Hilton, DO, discusses breast cancer management

In a recent interview with Contemporary OB/GYN, Christie Hilton, DO, director of Academic Breast Oncology at the Allegheny Health Network, discussed recent trends in breast cancer and how health care providers, especially ob-gyns, can support their patients.

According to Hilton, breast cancer is the most common cancer among women in the United States, accounting for approximately 30% of all new female cancer cases. In 2024, it is estimated that 310,000 patients will be diagnosed with invasive breast cancer, with 42,000 deaths. While these figures highlight the gravity of breast cancer, they also point to improved survival rates, emphasizing the importance of early detection through screenings such as mammograms.

A key focus of the conversation was the role ob-gyns play in early detection and patient education. Hilton stressed that although the median age for breast cancer diagnosis is 62 years, many women diagnosed are younger, underscoring the need for vigilance among younger patients. Ob-gyns can help by encouraging self-exams, discussing family history, and guiding patients through appropriate screening timelines. Breast self-awareness and clinical checks are crucial, as the majority of breast cancer cases are sporadic, not hereditary, with only 5% to 10% linked to family history.

The importance of educating patients is another major point. Many women believe that a lack of family history makes them less likely to develop breast cancer, but the reality is that 1 in 8 women will face this diagnosis, most without a hereditary predisposition. Educating women about the importance of regular screenings and mammograms, which can detect cancer early even when there are no symptoms, is critical in improving outcomes.

Finally, Hilton mentioned tools such as the Gail and Tyrer-Cuzick risk calculators, which can help patients assess their personal risk based on family history and other factors. Breast density, often included in mammogram reports, can also indicate the need for additional screening.

Hilton expressed optimism about breast cancer treatment advances, noting that new therapies are continuously being developed. She emphasized the importance of awareness, understanding one’s personal risk, and the life-saving potential of screenings.